Targeting IgE antibodies by immunoadsorption in atopic dermatitis

Michael Kasperkiewicz*, Enno Schmidt, Ralf J. Ludwig, Detlef Zillikens

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

One major hallmark of atopic dermatitis (AD) is the elevated level of total serum IgE, which has been reported to be partly of the autoreactive type in a subset of patients. Immunoadsorption (IA) has been successfully applied in various classical autoantibody-mediated diseases such as pemphigus. Recent reports proposed the use of IA also for patients with severe AD and high total serum IgE levels. In this mini-review, we summarize the current knowledge about this novel treatment approach for AD and briefly discuss the so far incompletely known role of autoreactive IgE as potential target of IA therapy in this common inflammatory skin disorder.

OriginalspracheEnglisch
Aufsatznummer254
ZeitschriftFrontiers in Immunology
Jahrgang9
AusgabenummerFEB
Seitenumfang5
DOIs
PublikationsstatusVeröffentlicht - 19.02.2018

Fingerprint

Untersuchen Sie die Forschungsthemen von „Targeting IgE antibodies by immunoadsorption in atopic dermatitis“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren